Acceleron Recognized as One of the Top 50 Venture-Backed Companies in the United States

Acceleron Pharma, a Cambridge pharmaceutical company developing therapeutics to modulate growth of cells and tissues, has been recognized by VentureSource, a unit of Wall Street Journal owner News Corp. as one of the top 50 venture capital-backed companies in the US. Acceleron is developing a soluble receptor for myostatin (ACE 031) for ALS and Muscular Dystrophy.

Click here to read more.

Share this: